

− Long-Term Results from the Phase 3 ALTA 1L Trial Established ALUNBRIG as a Superior First-Line Treatment Compared to Crizotinib for People...


MONTREAL–(BUSINESS WIRE)–The International Federation of Air Line Pilots’ Associations (IFALPA) is closely monitoring the developments related to this morning’s tragedy of PIA...


SHANGHAI–(BUSINESS WIRE)–OCO Global, a leading specialist trade and investment advisory firm has today announced the opening of its new office in Shanghai,...


The plant in Japan marks a milestone event for Fresh Del Monte Produce, showcasing the company’s aggressive growth plan and innovation in...


BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced a transaction...


LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–Infiniti Research is a leading provider of market intelligence services to businesses around the globe. For over 15 years, Infiniti has...


BEIJING–(BUSINESS WIRE)–New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (UFH),...


First-in-human phase 1 trial initiated with DS-6157, a GPR20 directed ADC, in patients with advanced gastrointestinal stromal tumor (GIST) GIST is a...


NEW YORK & LONDON & HONG KONG–(BUSINESS WIRE)–Jefferies announced today that it will hold a Global Coronavirus Relief Charity Day on May...


HANGZHOU, China–(BUSINESS WIRE)–Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988, “Alibaba” or “Alibaba Group”) today announced its financial results for the...